- Home
- FF vs GNLX Comparison
FF vs GNLX Comparison
Compare FF & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FF | GNLX |
|---|---|---|
| Founded | N/A | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 148.1M | 124.8M |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | FF | GNLX |
|---|---|---|
| Price | $4.54 | $2.69 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $19.75 |
| AVG Volume (30 Days) | ★ 404.2K | 179.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.58% | N/A |
| EPS Growth | N/A | ★ 18.10 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $8,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.09 | $1.99 |
| 52 Week High | $4.94 | $8.54 |
Technical Indicators
Market Signals| Indicator | FF | GNLX |
|---|---|---|
| Relative Strength Index (RSI) | 69.83 | 45.41 |
| Support Level | $3.80 | $2.31 |
| Resistance Level | $4.94 | $2.80 |
| Average True Range (ATR) | 0.28 | 0.16 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 63.75 | 30.30 |
Price Performance
Historical ComparisonAbout FF FutureFuel Corp.
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.